Dr. Suresh is a Clinical Professor at the State University of New York at Buffalo. He completed his PhD in computational cell biology, anatomy and pathology, MS in Oral biological sciences and specialty training in Oral and Maxillofacial Pathology all from the University at Buffalo, State University of New York. Dr. Suresh  has over 25 years of experience in pathology and laboratory medicine. He is board-certified in Oral and Maxillofacial Pathology by the American Board of Oral and Maxillofacial Pathology and American Board of Medical Laboratory Immunology.  He has authored numerous publications, book chapters, and holds several patents and maintains various research collaborations with investigators throughout the World. 

Dr. Shen earned his PhD in Biological Sciences from the University at Buffalo (UB) in 2003, followed by postdoctoral training at UB’s School of Medicine and Biomedical Sciences. He later joined UB's Department of Medicine as a research assistant professor, where he focused on investigating the early events that lead to the development of autoimmune diseases and lymphomas. In 2015, Dr. Shen transitioned into clinical laboratory work, with a special emphasis on developing novel laboratory-developed tests (LDTs) to meet clinical needs. In 2024, he received his Certificate of Qualification (CQ) as a lab director from the New York State Department of Health, with certifications in Diagnostic Immunology, Genetic Testing, Oncology (Molecular and Cellular Tumor Markers), and Virology.

Dr. Patricia A. Mowery-Rushton, a Diplomat of the American Board of Medical Genetics and Genomics in Clinical Cytogenetics, has more than 30 years of experience in cytogenetics and molecular medical genetics. Dr. Rushton received her PhD and clinical fellowship at the University of Pittsburgh, School of Medicine and Graduate School of Public Health.  Before joining KSL, Dr. Rushton was the director of cytogenetics at Signature Genomics, a division of Perkin Elmer, from 2011 to 2014. She has also held leadership positions in cytogenetics at Genzyme Genetics/Integrated Genetics in Santa Fe, NM and Children’s Hospital of Pittsburgh. In her new role as laboratory director and site leader, Dr. Rushton will provide technical expertise in diagnostics and test development for KSL’s genetic testing services. This includes clinical oversight of the cytogenetic and FISH group, whose primary focus is on hematologic oncology with planned growth into solid tumor and prenatal genetics. In the past, Dr. Rushton’s work has focused on cytogenetics and molecular rearrangements in leukemia, and she will translate that experience into the expansion of the genetics program that KSL is developing. Dr. Rushton has a strong record of research and brings an extraordinary and diverse body of expertise and accomplishments to KSL.  As Dr Rushton states “One of my goals is to bring improved client contact to the genetics division, and to ensure that appropriate understanding of what the testing information can provide the physician.  I believe and strive to establish a partnership with the pathologists and physicians in managing patient care”.

Dr. Raminder Grover is a Diplomate of the American Board of Medical Microbiology. She is certified by the New York State Department of Health in Diagnostic Immunology and has years of clinical laboratory experience. She worked with Dr. Beutner for years gaining experience in diagnostic studies for autoimmune skin diseases. She specializes in skin immunopathology, immunofluorescence assays, ELISA and immunoblot assays for the diagnosis of autoimmune skin and mucous membrane diseases. She is a volunteer faculty in the Department of Dermatology at SUNY, Buffalo and also has authored research papers in skin autoimmunity, microbiology and virology.

Megan has over 20 years of experience in laboratory science and management and is a NYS Certified Clinical Laboratory Technologist with an ASCP certification in Cytogenetics. She received her Biology B.A. degree from the University at Buffalo. Upon graduation, Megan specialized in Cytogenetics, with training at Genetic Diagnostic Labs and the preeminent Roswell Park Cancer Institute (RPCI), focusing on acquired chromosome abnormalities developed during cancer through both karyotyping and FISH techniques.  At RPCI, she also gained expertise in assay development with a focus on FISH and cytogenetic automated scanning platforms, which greatly improved the speed and quality of test results. This knowledge and expertise was brought to KSL Diagnostics, where NYS LDT assay development and turning LDTs into functioning, efficient clinical services is part of the KSL mission. Megan leads the operational initiatives at KSL Diagnostics, as well as established programs including the Diagnostic Immunology,  Biochemical Genetics, and Beutner Laboratory Departments. She recognizes that a patient is connected to every sample and leads the laboratory staff to deliver the highest quality test results for better treatment and care.

Dr. Shanahan received his doctorate degree in immunology from the Temple University School of Medicine in Philadelphia, PA, and trained as a post-doctoral fellow in clinical laboratory immunology at the McGill University Royal Victoria Hospital in Montreal, PQ. He is certified by the American Board of Medical Laboratory Immunologists. He has directed transplant immunology and HLA laboratories at the Erie County Medical Center, Strong Memorial Hospital, Buffalo General Hospital, Upstate New York Transplant Services, and Immco Diagnostics, and has held faculty appointments with the University of Buffalo and University of Rochester Medical Schools.

Dr. Aftab specializes in hematopathology. She works with all Kaleida Health facilities and the Erie County Medical Center and is based at Buffalo General Medical Center where she serves as the site medical director. Dr. Aftab is also an assistant professor at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo.

Dr. Kramer received her PhD and DDS degrees from the University at Buffalo, State University of New York. She completed her specialty training in Oral and Maxillofacial Pathology at Long Island Jewish Medical Center and her post-doctoral studies at the Feinstein Institute for Medical Research. She is a fellow in the American Academy of Oral and Maxillofacial Pathologists and a diplomate in the American Board of Oral and Maxillofacial Pathology. Dr. Kramer is currently an associate professor in the Department of Oral Biology and she holds adjunct appointments within the Departments of Oral Diagnostic Sciences and Microbiology and Immunology at the University at Buffalo. Dr. Kramer conducts NIH-funded research in the area of immune dysfunction in Sjögren’s syndrome and she has authored numerous manuscripts detailing the role of immune cells in this disease. She serves as a reviewer for many scientific journals and is an active member of several scientific societies, including the American Association for Dental, Oral and Craniofacial Research, the American Association of Immunologists and the Society for Leukocyte Biology. Dr. Kramer has worked as a diagnostic immunologist and oral pathologist since 2014.